Cargando…
Docetaxel‐induced interstitial lung disease among patients with breast cancer: a case series and review of literature
Taxane‐induced pneumotoxicity is rare. However, 1–5% of patients taking docetaxel may develop severe pneumotoxicity. This has been limited to case reports in the literature. We report seven breast cancer patients who developed docetaxel‐induced diffuse parenchymal lung disease (DPLD) of an organizin...
Autores principales: | Hettiarachchi, Sanjeewa Malinda, Thilakaratne, Dilanka, Dharmasena, Dawpadee, Rathnapala, Amila, Abeysinghe, Prasad, Perera, Eshanth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8200505/ https://www.ncbi.nlm.nih.gov/pubmed/34136263 http://dx.doi.org/10.1002/rcr2.802 |
Ejemplares similares
-
Interstitial lung disease induced by docetaxel and ramucirumab chemotherapy after nivolumab treatment
por: Okeya, Komugi, et al.
Publicado: (2020) -
Different Outcomes of “Silent Hypoxia” in Patients with COVID-19 Pneumonia: A Case Series and Literature Review
por: Ratnayake, Ashani, et al.
Publicado: (2021) -
Sertraline-Associated Interstitial Lung Disease: A case series and Literature Review
por: Izhakian, Shimon, et al.
Publicado: (2021) -
Sex and gender in interstitial lung diseases
por: Kawano-Dourado, Leticia, et al.
Publicado: (2021) -
The world of rare interstitial lung diseases
por: Buschulte, Katharina, et al.
Publicado: (2023)